01:26:44

ועידת ישאל ללכידות חברתית 2022

01:01:30

How Can Ketamine Providers Ensure the Best Outcome for Their Patients?

00:49

Ketamine Delivery, Patient Success and Ethics New Webinar Sign Up Today!

46:09

Can Ketamine Help with the Prevention of Teen Suicide, Depression and Anxiety?

59:36

How to Navigate the Mental Health Journey of a Loved One?

01:00:10

The Potential of Psychedelics & Ketamine in Women's Health

01:01:03

Is Ketamine a Psychedelic: Creating Common Language | Webinar Replay

38:45

Are the Benefits of Microdosing Psychedelics Real?

45:58

The Non Medical Potential of Psychedelics Love, Creativity and Cognition

42:28

Can Psychedelics Heal If There's No Trip?

45:39

Psychedelics are Here How Can We Pave the Way to Normalization & Accessibility?

48:29

How Research is Pushing the Psychedelic Movement Forward

47:18

Ketamine Is Changing the Way We Treat Mental Health Here's How

16:58

How Do You Know If Psychedelics Are Safe?

35:21

This Is How Tech Will Transform Our Access To Psychedelics

10:28

Wesana and PsyTech Close Up Conversation

50:22

What Can We Do to Guarantee Social Equity in the Emerging Psychedelic and Plant Medicine Space

47:47

Here's How to Set Up a Psychedelic Company

45:26

How Big Will the Psychedelic Market Go? A Look at Mergers, Funding and Valuations

01:05:20

Innovation in Psychedelics Funding Competition at PsyTech's 2021 Pitch Event

15:35

This is How Psychedelics Are Changing the Way We Do Business

16:02

The Potential Power of Psychedelics for Women's Health

44:12

Here's How Psychedelics Companies Should Raise Capital

15:00

Are Natural Psychedelic Compounds Better Than Synthetic?

44:43

How Do You Build a Psychedelics-Focused Company the Right Way?

25:48

Psychedelics Today Interviews Psytech's CEO Hayim Raclaw and CMO Abid Nazeer.

02:09

Psytech Summit 2021 PsyTech summit 2021 What Are You Excited About?

00:42

PsyTech Summit 2021

01:23:15

When Will Psychedelics Become Legal in America?

01:12:41

Webinar Replay: Can Psychedelic Therapies Help Cure PTSD and Head Trauma Injuries?

01:32:50

PsyTech Roundtable: Clinicians and Psychiatrists Discuss the Future of Ketamine Therapy

01:05:22

Psychedelic Investments Pitfalls and Opportunities To Watch Out For

37:36

How Psychedelic Medicine Offers us a Pathway Toward Healing

07:15

How Novamind is Providing Global Access to Psychedelic Medicine

15:29

Money and the Mind: How Investors Should Rethink Financing and Funding Psychedelic Therapies

05:37

This Technology is a Vital Tool for Ketamine Clinicians

25:36

The Challenges and Opportunities of Psychedelic Therapies in Australia

17:41

The Potential of Visionary Plant Medicine

13:53

Psychedelic Therapies A New (and Better) Way to Treat Addiction

14:46

This is How We Can Bring DMT Assisted Therapies to the Public

30:43

Israel’s Role in Psychedelic Research and Education

14:51

Let’s Discuss Patents and Psychedelics

51:55

Where Will Psychedelic Healthcare Be in 10 Years?

04:34

Investing in Psychedelics How Will Numinus Push the Movement Forward?

16:13

DoubleBlind’s Founders on the Media’s Role in Psychedelics

21:01

The Pros and Cons of Ayahuasca’s Globalization

17:57

Can Ibogaine Break Our Opioid Dependence?

20:48

This is Why We Should Decriminalize Psychedelics

17:20

How Should Psychedelics Play a Role in Capitalism?

05:53

Here’s What Psychedelic Activists Should Do Right Now

39:47

Watch This Researcher Take Ayahuasca in the Amazon

06:33

Using Data to Understand Psychedelics in the Real World

17:42

Crowdsourcing Psychedelic Research

14:29

This is How We Can Bring Psychedelics Into Mainstream Medicine

32:39

What’s Better for Treating Depression: Psilocybin or Ketamine?

29:11

What's the Future of Psychedelic Medicine Beyond 2020?

03:11

Welcome To PsyTech Summit 2020

14:29

Can We Achieve True Social Equity in Psychedelics?

21:20

Can Psilocybin Therapies Be the Key to Solving Depression?

48:22

Rick Doblin On How Psychedelic Therapy Has Changed